reboxetine has been researched along with Cognition Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellinghieri, PM; Bruno, A; De Fazio, P; Muscatello, MR; Pandolfo, G; Spina, E; Zoccali, R | 1 |
| Faragian, S; Fuchs, C; Pashinian, A; Poyurovsky, M | 1 |
| Ferguson, JM; Schwartz, GE; Wesnes, KA | 1 |
| Buechler, J; Oehler, J; Reuster, T; Winiecki, P | 1 |
| Ferguson, JM; Mendels, J; Schwart, GE | 1 |
3 trial(s) available for reboxetine and Cognition Disorders
| Article | Year |
|---|---|
Reboxetine adjuvant therapy in patients with schizophrenia showing a suboptimal response to clozapine: a 12-week, open-label, pilot study.
Topics: Adult; Antipsychotic Agents; Clozapine; Cognition Disorders; Drug Therapy, Combination; Female; Humans; Male; Morpholines; Pilot Projects; Reboxetine; Schizophrenia | 2014 |
Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Paroxetine; Placebos; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2003 |
Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Sleep Initiation and Maintenance Disorders | 2002 |
2 other study(ies) available for reboxetine and Cognition Disorders
| Article | Year |
|---|---|
Effect of the selective norepinephrine reuptake inhibitor reboxetine on cognitive dysfunction in schizophrenia patients: an add-on, double-blind placebo-controlled study.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Reboxetine; Schizophrenia; Schizophrenic Psychology; Young Adult | 2009 |
Influence of reboxetine on salivary MHPG concentration and cognitive symptoms among patients with alcohol-related Korsakoff's syndrome.
Topics: Alcohol Amnestic Disorder; Cognition Disorders; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Morpholines; Multivariate Analysis; Reboxetine; Saliva; Statistics, Nonparametric | 2003 |